Pharma Industry Marketing

 

Abstract 2012

Disease mongering is the promotion of pseudo-diseases by the pharmaceutical industry aiming at economic benefit. Medical equipment manufacturers, insurance companies, doctors or patient groups may also use it for monetary gain or influence. It has increased in parallel with society's 'medicalisation' and the growth of the pharmaceutical complex. Due to massive investments in marketing and lobbying, ample use of internet and media, and the emergence of new markets, it is becoming a matter of concern, and policy makers should be aware of its perils and consequences.

A pdf published by the European Parliament Department of Environment, Public Health and Food Safety

 

Amsterdam 2010 SELLING SICKNESS Conference

Part 1 of Selling Sickness and promotion of disease to sell drugs

Part 2 of Selling Sickness conference 2010

Part 3 of Selling Sickness conference Amsterdam 2010

supported by the WHO and Dutch Health Authorities at which APRIL presented a Poster The Dianette Story

A conference in Amsterdam October 2010 at which Dr Peter Mansfield who founded 'Healthy Skepticism' and speaks about the untrustworthy pharmaceutical industry in an interview.

Some of the talks are available here 

Concern over the promotion of disease to sell drugs  

Many of the talks are enlightning and the DSM is discussed by a contributor to DSM 1V Allan Francis

This is a video of Dr Allen J Francis speaking about his concerns about DSM5

Tamiflu - Pharmaceutical Promotion of drugs with doubtful benefit for patients -

UK Government Health Committee Inquiry into the Influences of the Pharmaceutical Industry

UK Regulation of Medicines